ReviewMolecular neurodegeneration2026
Lipid alterations in hereditary peripheral neuropathies: common mechanisms in disease heterogeneity?
Review in Molecular neurodegeneration, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
While the impact of lipid alterations on central nervous system disorders is well-studied, increasing evidence indicates that lipids also play an important role in the pathology of hereditary peripheral neuropathies (HPN). It is becoming clear that Schwann cells and neurons in peripheral nerves heavily depend on lipids for membrane interactions, (sub)cellular signalling, and the formation of myelin sheaths. In support of this notion, disturbances in the level and composition of lipid classes, including phospholipids, sphingolipids and cholesterol, perturb normal functioning of peripheral nerves. Intriguingly, lipid disturbances seem to be a common denominator within the heterogeneous group of HPN, with hindrances in cholesterol and sphingolipid metabolism primarily influencing Schwann cell and neuron homeostasis, respectively. In this review, we provide an overview of lipid disturbances in various HPN with the goal of finding main commonalities between the different diseases and to identify potential novel treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.